Bondi, other AGs target drug industry in opioid probe

Florida Attorney General Pam Bondi and other attorneys general are targeting drug manufacturers and distributors as well as the insurance industry, in an effort to address the nation’s opioid epidemic.

Drug overdose is the leading cause of accidental death in the country, with 52,404 fatal overdoses reported in 2015, according to the American Society of Addiction Medicine. Opioid addiction drove the epidemic with 20,101 overdose deaths related to prescription pain relievers and 12,990 deaths related to heroin.

Florida, where overdose deaths have spiked over the past two years, is one of the epicenters of the opioid crisis, fueled in part by the widespread use of fentanyl, a deadly painkiller sometimes mixed with heroin.

Bondi and a group of attorneys general are demanding documents and information from pharmaceutical manufacturers and distributors related to their opioid business.

The information requests are part of an effort by 41 states to crack down on the opioid crisis.

Bondi, who was appointed by President Donald Trump to serve on the White House’s Opioid and Drug Abuse Commission, has made prescription drug abuse one of her top priorities since she took office in 2011.

“Florida citizens continue to become addicted to opioids and die daily—meanwhile, prescription drug manufacturers, distributors and the medical profession all point fingers at each other as the cause of this national crisis,” Bondi said in a press release issued Tuesday. “This far-reaching multistate investigation is designed to get the answers we need as quickly as possible. The industry must do the right thing. If they do not, we are prepared to litigate.”

On Monday, Bondi joined a separate group of attorneys general who want insurers to make it easier for patients to receive alternative pain management treatments.